Göm menyn

Publications for Ulrika Nilsson

Co-author map based on Web of Sciences articles 2007-

Publications mentioned in social media 2 times*

Journal Articles

Ulrika Nilsson, Niina Saarinen, Annelie Abrahamsson, Tarja Nurmi, Sofia Engblom and Charlotta Dabrosin
  Tamoxifen and Flaxseed Alter Angiogenesis Regulators in Normal Human Breast Tissue In Vivo
  PLoS ONE, 2011, 6(9), .
   Fulltext  PDF  
 Web of Science® Times Cited: 20

Ulrika Nilsson, Annelie Abrahamsson and Charlotta Dabrosin
  Angiogenin Regulation by Estradiol in Breast Tissue: Tamoxifen Inhibits Angiogenin Nuclear Translocation and Antiangiogenin Therapy Reduces Breast Cancer Growth In vivo
  Clinical Cancer Research, 2010, 16(14), 3659-3669.
 Web of Science® Times Cited: 32

Ulrika Nilsson, Jill A. Jönsson and Charlotta Dabrosin
  Tamoxifen decreases extracellular TGF-beta 1 secreted from breast cancer cells - A post-translational regulation involving matrix metalloproteinase activity
  Experimental Cell Research, 2009, 315(1), 1-9.
   Fulltext  PDF  
 Web of Science® Times Cited: 14

Ulrika W. Nilsson, Stina Garvin and Charlotta Dabrosin
  MMP‐2 and MMP‐9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells
  Breast Cancer Research and Treatment, 2007, 102(3), 253-261.
 Web of Science® Times Cited: 54

Ulrika W. Nilsson, J. A. Jönsson and Charlotta Dabrosin
  Tamoxifen downregulatesTGF‐β1 protein levels via matrix metalloproteinase activity in breast cancer in vivo
  , 2007, , .

Ulrika W. Nilsson and Charlotta Dabrosin
  Estradiol and tamoxifen regulate endostatin generation via matrix metalloproteinase activity in breast cancer in vivo
  Cancer Research, 2006, 66(9), 4789-4794.
 Web of Science® Times Cited: 45

Stina Garvin, Ulrika W. Nilsson, Fredrik R. M. Huss, Gunnar Kratz and Charlotta Dabrosin
  Estradiol increases VEGF in normal human breast studied by whole-tissue culture
  Cell Tissue Research, 2006, 325(2), 245-251.
 Web of Science® Times Cited: 21

Stina Garvin, Ulrika W. Nilsson and Charlotta Dabrosin
  Effects of estradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells
  British journal of cancer, 2005, 93(9), 1005-1010.
 Web of Science® Times Cited: 58

Conference Articles

Ulrika Nilsson and Charlotta Dabrosin
  Anti-angiogenic effects of tamoxifen in breast cancer by decreased secretion and reduced nuclear accumulation of angiogenin
  CANCER RESEARCH ISSN 0008-5472: Volume 69 Issue 2, 2009.

Ph.D. Theses

Ulrika W. Nilsson
  Effects of sex steroids and tamoxifen on matrix metalloproteinase activity and generation of endostatin in the breast

  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.


Responsible for this page: Peter Berkesand
Last updated: 2010-08-30